List view / Grid view
20 May 2005 | By Stephen W. Hoag, Ph.D., School of Pharmacy, University of Maryland
Many of the physical factors that affect tablet quality are formed during compaction. Thus, the accurate measurement of tablet compaction will help researchers to better understand compaction and die-wall stress measurements are a critical aspect of being able to measure and understand the three-dimensional nature of compaction.
28 October 2021 | By Alejandro Toro (Amgen Manufacturing Limited), Badua Merheb (Amgen Manufacturing Limited), Melvin Ortiz (Amgen Manufacturing Limited), Pablo J Rosado (Amgen Manufacturing Limited)
Transition Analysis (TA) is a method traditionally used to evaluate the condition and integrity of a chromatography column. However, this method generally requires conducting complex data post‑processing and calculations which are hard to automate and to run in real time during the manufacturing process. Thus, completing the TA offline leads…
16 January 2018 | By European Pharmaceutical Review
This supplement contains a collection of application notes and whitepapers from some of the leading suppliers to the pharmaceutical industry...
12 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The global generic drugs market continues to grow. With increasing demand for more accessible medication, pharmaceutical companies are harnessing the benefits offered by generic drugs. Here are the top five generic drugs makers by revenue.
6 February 2017 | By Niamh Marriott (European Pharmaceutical Review)
European Pharmaceutical Review has been keeping the industry informed for 21 years and continues to bring insights into current and emerging technologies, contributions from recognised figures in the life science community and of course, the latest and most up to date news. To celebrate our success, we will be counting down…
24 October 2016 | By Niamh Louise Marriott, Digital Content Producer
We're live at ISPE 2016 Europe Conference on Biotechnology! Check this stream for live updates of the event...
3 September 2019 | By Christian Rack (Qualified Person - B. Braun Gruppe)
The efficient handling of information and resources is key for achieving success within a commercial organisation. Against the backdrop of ICH Q10 – the International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use – Christian Rack discusses five things you can implement right now to…
29 May 2009 | By
Much has been published elsewhere about the limitations of the compendial microbiological methods and the needs of current Pharmaceutical manufacturing, in particular related to the adoption of PAT as a quality tool1-4. Rapid Microbiology is seen by many as a tool for addressing a number of these limitations5,6. Rather less…
29 April 2020 | By Dr Chris Palmer (WMFTG), Dr John Milne (National Institute for Bioprocessing Research and Training), Jim Marjeram (O’Hara Technologies)
There are many challenges faced by the biopharmaceutical industry in order to develop and provide sufficient drugs to treat a growing and ageing population. This article discusses whether continuous processing provides the solution.
26 September 2019 | By Gillian Ewan (PragmatIC)
This article explores the potential of readily available technology to address current traceability challenges as well as more wide-ranging issues in the pharmaceutical industry.
14 October 2019 | By Victoria Rees (European Pharmaceutical Review)
Researchers have revealed the top 10 drugs by annual revenue in 2025. Here, we investigate the indications that necessitate these treatments and the delivery systems they employ.
19 December 2018 | By European Pharmaceutical Review
Keeping up with the latest developments in pharma.
11 November 2005 | By Steve Doherty and Aaron Garrett, Manufacturing Science and Technology, Mark LaPack, Process Research and Development, Eli Lilly and Co.
Optical techniques can not address every application need, so the well-equipped PAT toolbox must include a broad array of technologies. One analytical tool that has been less-published but no less useful than the optical methods is mass spectrometry. This article provides a brief review of some of the published uses…
23 November 2007 | By
High Content Screening (HCS) is becoming increasingly utilised as an early drug-discovery and basic research tool for defining the functions of genes, proteins and other biomolecules in normal and abnormal cellular functions. HCS involves the integration of a number of preparation steps which include; cell-sample preparation, fluorescent labelling, image acquisition,…
17 February 2021 | By Bastiaan Dickhoff (DFE Pharma), Sunil Kumar Nataraj (DFE Pharma), Thontesh GC (Apotex Pharmaceuticals)
Many biologic formulations use a variety of high-purity injectable grade disaccharide excipients to ensure functionality and stability of the final product. In this article, Sunil Kumar Nataraj, Bastiaan Dickhoff and Thontesh GC explore the use of these sugars in the stabilisation of biologics and provide recommendations to manufacturers for enhancing…
